FDA Inspection 1037529 — Heritage Pharmaceuticals Inc
The FDA completed an inspection of Heritage Pharmaceuticals Inc on Dec 14, 2017 in East Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 14, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- East Brunswick, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)